At what enterprise value was EDL acquired in 2024?

During the acquisition of EDL by DENTRESSANGLE in 2024, the transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR.

What was the EV/EBITDA of EDL when it was acquired by DENTRESSANGLE?

The estimated EV/EBITDA multiple for EDL is in the range of 15x - 25x.

When was EDL acquired by DENTRESSANGLE?

EDL was acquired by DENTRESSANGLE in 2024.

What was the revenue of EDL at the time of the deal?

The revenue of EDL at the time of the deal is estimated to be in the range of 25M - 50M EUR.

What was the EBITDA of EDL during the acquisition?

EDL's EBITDA is estimated to be in the range of 5M - 25M EUR.

How is the data for the EDL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the EDL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/dentressangle-prend-le-relai-dabenex-chez-edl-2120735

What is the average EV/EBITDA multiple for the TMT (Tech, Media, Telecom) sector in 2026?

The average EV/EBITDA multiple for the TMT (Tech, Media, Telecom) sector in 2026 is 15.1x.

← DATABASE

Home Database TMT (Tech, Media, Telecom)EDL

09/2024

EDL acquired by DENTRESSANGLE

FRANCE Software / Industry-Specific Software / Healthcare EV 100M - 350M EUR

Context

DENTRESSANGLE Capital acquired a majority stake in EDL from the private equity firm Abenex. This transaction was carried out at a high valuation multiple, reflecting EDL's exceptional profitability (50% EBITDA margin) and dominant market position. The management team reinvested significantly alongside DENTRESSANGLE. The strategic rationale for this "LBO bis" is to accelerate EDL's European footprint through targeted build-up acquisitions and to enhance its technological lead by further integrating AI into the Xplore suite. This transaction marks a successful exit for Abenex, which had supported the group since 2021, overseeing its expansion into the DACH region and Belgium.

Previously, Edl had been acquired in an LBO by Abenex in 2021.

EDL, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the TMT (Tech, Media, Telecom) sector (15.1x).

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

EDL is a leading European software publisher specialized in medical imaging and diagnostic services. The company's flagship product, the Xplore software suite, provides public and private healthcare institutions with a full-web, integrated solution designed to optimize the operation of medical imaging platforms. EDL s solutions are highly regarded for their technical robustness, ergonomics, and functional depth, covering everything from appointment scheduling to billing and teleradiology.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Other operations with EDL

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
05/2021	ABENEX	EDL	FRANCE	Healthcare

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of EDL by DENTRESSANGLE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: dentressangle